Predictors of rebleeding and in-hospital mortality in patients with nonvariceal upper digestive bleeding

Table 3 Clinical and endoscopic features of the study population: Association with rebleeding

Parameter	No-rebleeding (no. pts, %)	Rebleeding, (no. pts, %)	Total no. patients, %	Total (% out of entire batch)	P value
Rockall score	1435 (92.16)	122 (7.84)	1.557 (100)	100	< 0.001
Simple therapy	143 (82.18)	31 (17.82)	174 (100)	11.01	< 0.001
Combined therapy	318 (84.8)	57 (15.2)	375 (100)	23.72	< 0.001
SBP (mmHg) < 100	240 (83.33)	48 (16.67)	288 (100)	18.22	< 0.001
Pulse (beats per minute) > 100	404 (87.26)	59 (12.74)	463 (100)	29.32	< 0.001
Cardiovascular comorbidities	901 (92.32)	75 (7.68)	976 (100)	61.73	0.857
Diabetes mellitus	272 (91.89)	24 (8.11)	296 (100)	18.72	0.815
Respiratory comorbidities	184 (89.32)	22 (10.68)	206 (100)	13.03	0.096
Renal comorbidities	303 (91.82)	27 (8.18)	330 (100)	20.87	0.759
Liver cirrhosis	128 (90.78)	13 (9.22)	141 (100)	8.92	0.504
Neoplasias	232 (90.63)	24 (9.38)	256 (100)	16.19	0.298
Neurologic comorbidities	202 (94.39)	12 (5.61)	214 (100)	13.54	0.202
Obesity	125 (93.28)	9 (6.72)	134 (100)	8.48	0.631
Sepsis	38 (80.85)	9 (19.15)	47 (100)	2.97	0.003
Acute pancreatitis	6 (75)	2 (25)	8 (100)	0.51	0.068
Acute abdomen	4 (66.67)	2 (33.33)	6 (100)	0.38	0.019

SBP: Systolic blood pressure.